SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Mechanisms and novel therapeutic roles of bitter taste receptors in diseases.

Theranostics · 2025-03-03

DOI: 10.7150/thno.107406PMID: 40213652

Open accessreview-article; Review; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

Bitter taste receptors (TAS2R) are expressed in the oral cavity, intestine, airways, and vascular smooth muscle, where they regulate physiological processes, including immune responses. However, the activation of TAS2R triggers signaling pathways that influence inflammation, metabolism, and cell proliferation, suggesting their potential as therapeutic targets for diseases such as Alzheimer's disease, Parkinson's disease, asthma, and cancer. Bitter compounds capable of activating TAS2R have shown potential in modulating these pathways, presenting novel opportunities for drug development. This review examines the expression of TAS2R across diverse tissues, their complex physiological roles, and potential therapeutic applications, including disease management and targeted drug delivery.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.